Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Profund Advisors LLC

Profund Advisors LLC decreased its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC) by 69.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 13,045 shares of the health services provider’s stock after selling 29,309 shares during the period. Profund Advisors LLC’s holdings in Teladoc Health were worth $128,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Allianz Asset Management GmbH increased its position in Teladoc Health by 15.4% during the 4th quarter. Allianz Asset Management GmbH now owns 604,238 shares of the health services provider’s stock worth $13,021,000 after purchasing an additional 80,805 shares during the period. Allspring Global Investments Holdings LLC grew its holdings in shares of Teladoc Health by 74.0% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider’s stock worth $311,000 after acquiring an additional 8,750 shares during the period. Janney Montgomery Scott LLC increased its stake in Teladoc Health by 188.7% in the 1st quarter. Janney Montgomery Scott LLC now owns 31,594 shares of the health services provider’s stock valued at $477,000 after purchasing an additional 20,651 shares in the last quarter. Vanguard Group Inc. raised its holdings in Teladoc Health by 11.8% during the fourth quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock worth $377,451,000 after purchasing an additional 1,855,480 shares during the last quarter. Finally, Pale Fire Capital SE purchased a new stake in Teladoc Health during the fourth quarter worth $8,960,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Stifel Nicolaus dropped their price target on Teladoc Health from $16.00 to $9.00 and set a “hold” rating for the company in a research report on Thursday, August 1st. JPMorgan Chase & Co. dropped their price target on Teladoc Health from $16.00 to $9.00 and set a “neutral” rating for the company in a research report on Monday, August 26th. Canaccord Genuity Group dropped their price target on Teladoc Health from $25.00 to $17.00 and set a “buy” rating for the company in a research report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft dropped their price target on Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a research report on Friday, August 2nd. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research note on Thursday, August 1st. Fifteen equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, Teladoc Health currently has an average rating of “Hold” and an average target price of $12.31.

Teladoc Health Stock Up 0.6 %

Shares of NYSE:TDOC opened at $8.46 on Monday. The stock’s 50-day moving average price is $7.93 and its two-hundred day moving average price is $10.62. The company has a current ratio of 1.66, a quick ratio of 1.62 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 12-month low of $6.76 and a 12-month high of $22.54. The firm has a market cap of $1.43 billion, a price-to-earnings ratio of -6.00 and a beta of 0.90.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.08. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. The firm had revenue of $642.44 million for the quarter, compared to analyst estimates of $649.34 million. On average, research analysts forecast that Teladoc Health, Inc. will post -1.18 EPS for the current year.

Insider Transactions at Teladoc Health

In other news, insider Vidya Raman-Tangella sold 3,857 shares of the firm’s stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $31,395.98. Following the transaction, the insider now directly owns 33,667 shares in the company, valued at approximately $274,049.38. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, insider Vidya Raman-Tangella sold 3,857 shares of the firm’s stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $31,395.98. Following the transaction, the insider now directly owns 33,667 shares in the company, valued at approximately $274,049.38. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Thomas Mckinley acquired 4,000 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was purchased at an average price of $7.69 per share, for a total transaction of $30,760.00. Following the completion of the acquisition, the director now owns 39,077 shares in the company, valued at $300,502.13. The disclosure for this purchase can be found here. Insiders have sold a total of 57,819 shares of company stock worth $442,204 in the last three months. 0.95% of the stock is currently owned by company insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.